Premier Medical names new chief scientific officer

LabPulse.com staff writers
Jul 27, 2021
2021 07 28 22 21 2792 2021 07 28 Brian Krueger 400

Premier Medical Laboratory Services has named Brian Krueger as its new chief scientific officer.

Krueger, the former technical director of research and development (R&D) at Labcorp, will be responsible for overseeing clinical assay development and communicating with the scientific and customer communities about laboratory capabilities, scientific product development, and the application of scientific research for medical advancements. Brian Krueger. Image courtesy of Premier Medical Laboratory Services.Brian Krueger. Image courtesy of Premier Medical Laboratory Services.
Latest in Research and Development
Molecule Social
Owlstone, FDA's OSEL partner to develop VOC ID methods
September 30, 2024
Body composition in patients treated with Ozempic
Sponsored
Body composition in patients treated with Ozempic
September 20, 2024
Infectious Diseases Research Social
NIH establishes pandemic preparedness research network
September 19, 2024
Blood Test Samples Lab Social
Humana, UnitedHealthcare change Z-code requirements for molecular diagnostic test claims
September 19, 2024
Related Stories
2020 02 08 00 11 9942 Virus Coronavirus 400
Health Topics
Premier Medical launches Virtual Lab
2020 01 21 22 13 2411 Virus Coronavirus 400
Emergency Use Authorization
Premier Medical to offer coronavirus testing
2019 04 17 00 53 3368 Dna Sequence 400
Product Launch
Premier Medical launches Patia's diabetes genetic test
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Research and Development
Owlstone, FDA's OSEL partner to develop VOC ID methods
By LabPulse.com staff writers
Owlstone Medical entered a research collaboration agreement with the FDA's Center for Devices and Radiological Health Office of Science and Engineering Laboratories (OSEL) to develop methods of identifying volatile organic compounds (VOCs) in breath.
September 30, 2024
Molecule Social
Cepheid partners with Fleming Initiative on antimicrobial resistance
By LabPulse.com staff writers
Diagnostics firm Cepheid has entered a partnership with the Fleming Initiative, a global collaboration established by the Imperial College Healthcare National Health Service Trust and Imperial College London to combat antimicrobial resistance.
September 26, 2024
Colorized scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA) bacteria (gold) interacting with a human neutrophil (red). Image captured at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, Montana.
NIH establishes pandemic preparedness research network
By LabPulse.com staff writers
The U.S. National Institutes of Health (NIH) has established a pandemic preparedness research network for research on the pathogens that are most likely to threaten human health.
September 19, 2024
Infectious Diseases Research Social
Humana, UnitedHealthcare change Z-code requirements for molecular diagnostic test claims
By LabPulse.com staff writers
Among the tests in focus are certain RNA- and DNA-based tests.
September 19, 2024
Blood Test Samples Lab Social
Multiregional clinical trial data on FDA watch for U.S. applicability
By LabPulse.com staff writers
Pivotal trials drawing on foreign clinical data in focus.
September 16, 2024
Fda Sign Dc Social
Mount Sinai Health gets $3.26M NIH grant for undiagnosed diseases center
By LabPulse.com staff writers
Mount Sinai Health received a four-year, $3.26 million grant from the U.S. National Institutes of Health (NIH) to establish the new Mount Sinai Center for Undiagnosed Diseases, the first Undiagnosed Diseases Network site in the New York metropolitan area.
September 17, 2024
Sequencing Dna Rna Social
HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
By LabPulse.com staff writers
Scientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.
September 6, 2024
Dna Sequencing Data Analysis Social
Seegene, Springer Nature launch PCR innovation program
By LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Research Money Social
Lumos Diagnostics extends deal to advance POC liver monitoring test to trials
By LabPulse.com staff writers
Lumos Diagnostics is expanding an existing deal with the Burnet Diagnostics Initiative that will advance a new point-of-care (POC) test for monitoring liver health in an upcoming clinical trial.
August 28, 2024
Liver Social
Qiagen ventures into chronic disease CDx
By LabPulse.com staff writers
Qiagen has expanded its agreement with AstraZeneca beyond oncology.
August 29, 2024
Business Handshake Intelligence Social
Scale Bio launches 100M cell challenge research initiative
By LabPulse.com staff writers
Scale Biosciences, in collaboration with Ultima Genomics and Nvidia, has launched a global initiative for single-cell research projects aimed at collectively analyzing 100 million cells or more across diverse biological systems and research areas.
August 19, 2024
Single Cell Analysis Social
Alpenglow Biosciences lands $24M for 3D pathology platform
By LabPulse.com staff writers
Company gets boost to commercialize direct-to-digital pathology platform and AI.
August 15, 2024
Money Hundred Bills Social
Page 1 of 41
Next Page